CLDI · Calidi Biotherapeutics, Inc.
$1.35
+0.03 (+1.89%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.41M
Shares
2.58M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-27 | 676,541 | 8,671,754 | 9,348,295 | 100.0% |
| 2026-07-20 | 1,791,888 | 56,714,540 | 58,506,428 | 100.0% |
| 2026-07-13 | 260,516 | 7,387,567 | 7,648,083 | 100.0% |
| 2026-07-06 | 568,089 | 5,668,363 | 6,236,452 | 100.0% |
| 2026-06-29 | 2,446,670 | 11,552,710 | 13,999,380 | 100.0% |
| 2026-06-22 | 1,252,487 | 19,322,795 | 20,575,282 | 100.0% |
| 2026-06-15 | 1,783,912 | 13,977,514 | 15,761,426 | 100.0% |
| 2026-06-08 | 2,429,517 | 16,176,228 | 18,605,745 | 100.0% |
| 2026-06-01 | 3,326,520 | 14,289,798 | 17,616,318 | 100.0% |
| 2026-05-25 | 930,251 | 8,571,470 | 9,501,721 | 100.0% |
| 2026-05-18 | 401,642 | 4,757,781 | 5,159,423 | 100.0% |
| 2026-05-11 | 1,487,128 | 10,574,228 | 12,061,356 | 100.0% |
| 2026-05-04 | 355,228 | 4,539,718 | 4,894,946 | 100.0% |
| 2026-04-27 | 5,194,503 | 75,624,070 | 80,818,573 | 100.0% |
| 2026-04-20 | 1,050,526 | 14,452,787 | 15,503,313 | 100.0% |
| 2026-04-13 | 567,615 | 9,952,151 | 10,519,766 | 100.0% |
| 2026-04-06 | 101,709 | 1,804,728 | 1,906,437 | 100.0% |
| 2026-03-30 | 28,298 | 1,223,452 | 1,251,750 | 100.0% |
| 2026-03-23 | 37,656 | 1,060,298 | 1,097,954 | 100.0% |
| 2026-03-16 | 34,839 | 600,007 | 634,846 | 100.0% |
| 2026-03-09 | 101,734 | 1,235,164 | 1,336,898 | 100.0% |
| 2026-03-02 | 201,103 | 2,742,052 | 2,943,155 | 100.0% |
| 2026-02-23 | 6,931 | 124,845 | 131,776 | 100.0% |
| 2026-02-16 | 3,945 | 159,481 | 163,426 | 100.0% |
| 2026-02-09 | 12,958 | 335,045 | 348,003 | 100.0% |
| 2026-02-02 | 8,024 | 250,064 | 258,088 | 100.0% |
| 2026-01-26 | 19,538 | 236,058 | 255,596 | 100.0% |
| 2026-01-19 | 14,807 | 209,143 | 223,950 | 100.0% |
| 2026-01-12 | 23,644 | 428,107 | 451,751 | 100.0% |
| 2026-01-05 | 5,289 | 133,800 | 139,089 | 100.0% |
| 2025-12-29 | 7,512 | 268,645 | 276,157 | 100.0% |
| 2025-12-22 | 6,846 | 199,786 | 206,632 | 100.0% |
| 2025-12-15 | 12,325 | 229,741 | 242,066 | 100.0% |
| 2025-12-08 | 29,752 | 163,089 | 192,841 | 100.0% |
| 2025-12-01 | 20,878 | 213,262 | 234,140 | 100.0% |
| 2025-11-24 | 11,583 | 129,804 | 141,387 | 100.0% |
| 2025-11-17 | 33,714 | 416,437 | 450,151 | 100.0% |
| 2025-11-10 | 29,432 | 535,109 | 564,541 | 100.0% |
| 2025-11-03 | 142,461 | 1,423,211 | 1,565,672 | 100.0% |
| 2025-10-27 | 27,102 | 335,770 | 362,872 | 100.0% |
| 2025-10-20 | 23,439 | 395,530 | 418,969 | 100.0% |
| 2025-10-13 | 19,704 | 435,963 | 455,667 | 100.0% |
| 2025-10-06 | 52,471 | 777,041 | 829,512 | 100.0% |
| 2025-09-29 | 25,131 | 439,982 | 465,113 | 100.0% |
| 2025-09-22 | 16,818 | 383,586 | 400,404 | 100.0% |
| 2025-09-15 | 34,846 | 347,685 | 382,531 | 100.0% |
| 2025-09-08 | 58,540 | 579,494 | 638,034 | 100.0% |
| 2025-09-01 | 80,022 | 641,845 | 721,867 | 100.0% |
Showing 1–48 of 48 weeks
Key facts
CIK
1855485
CUSIP
320703408
13F (30d)
15 filings
15 filers
Visit website
Investor relations